Member Info for ogm4

Cheers guys

Read the RNS:

"The patent application which provides the potential for 20 years of commercial exclusivity, discloses a novel diagnostic test AND precision treatment approach, identifying a subpopulation of patients with Type M immune disorder that are P140 super-responders. This approach can be used to treat up to 50 autoimmune diseases ("AutoIDs"), representing a major step forward in precision medicine."

The title is just the title, I am more interested in the contents to be honest! Treatment approach will be included.

Indeed as announced earlier today Boehringer paid Kyowa Kirin 640 million Euro for the license of a pre-clinical small-molecule program.

640 million Euro

743 million US Dollars

....

Lanstead out shortly will remove the lid and the share price will move upwards more easily.

Lanstead should be almost out by now

Expect another TR-1 shortly

Wow, publication in well respected scientific journals!...

That would be something!

.

If you dominate half a 250bn market, what sort of market cap would that justify?

Let me think about that one for a minute...

Cheers SmTch73.

Board is full of confidence indeed, yesterday's RNS is another step in the right direction, e.g. new website up and running, comprehensive data room implemtented now alive, corporate update to keep shareholders informed, deal still anticipated within say 8 weeks frm now. These must have been worked on already prior patent filing being granted across summer time. I am hearing the rights things folks.

Financial Update

ImmuPharma's cash runway has recently *** been extended into H2 2026 *** , by the exercise of warrants and enhanced monthly cash receipts under the current Lanstead Capital sharing agreement, the final settlement for which is expected in November.

*** ImmuPharma has no intention to raise further funds *** and will look to further strengthen its cash position as a result of deals with potential partners.

Also expect the shares to end up in more stickier hands over time reducing the free float.

I had a quick look on the new IMM website as announced today. I can't seem to find Avion being mentioned anywhere anymore, which if I recall correctly they were mentioned previously as one of the partners.

I could be wrong though...

"Patent protection expected until 2045."

Hi folks! Just came back from a long drive this morning. Noticed the RNS halfway at the stop at the fuel station - another great RNS! Decided to immediately invest another £600 pounds between fill up and coffee! All good- speak later!...

Hi folks! Just came from a long drive this morning. Noticed the RNS halfway at the stop at the fuel station - another great RNS! Decided to immediately invest another £600 pounds between fill up and coffee! All good- speak later!...

Good morning all,

Let's see if we get more big buys coming in today.

Dianthus offers up to $1B for China biotech's autoimmune 'pipeline in a product'

By Gabrielle Masson

Oct 16, 2025 10:57am

https://www.fiercebiotech.com/biotech/dianthus-offers-1b-china-biotechs-autoimmune-pipeline-product

Exciting times!...

I must admit I got excited by yesterday's rise during the last hour of trading. Big buys being filled, who knows.

Only 8-10 weeks left until year end.

We must be close to a commercial deal beig announced!

12.75p now!

+20% now

Bit of action last 1/2 hour!

11.44p paid